Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mutations in the TSC1 or TSC2 tumor suppressor genes lead to tuberous sclerosis complex (TSC), a dominant hamartomatous disorder that often presents with mental retardation, epilepsy and autism. The etiology of these neurological symptoms is unclear and the function of the TSC pathway in neurons is unknown. We found that in post-mitotic, hippocampal pyramidal neurons of mice and rats, loss of Tsc1 or Tsc2 triggered enlargement of somas and dendritic spines and altered the properties of glutamatergic synapses. Furthermore, loss of a single copy of the Tsc1 gene was sufficient to perturb dendritic spine structure. Morphological changes required regulation of the actin-depolymerization factor cofilin at a conserved LIM-kinase phosphorylation site, the phosphorylation of which was increased by loss of Tsc2. Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunostaining of hippocampi from these mice showed an increase in the downstream marker of mTORC1 activity, phospho-S6 ribosomal protein, along with the typical increase in cell body size relative to control (Fig. 8C and supplemental Fig. S6) (84).”
In the citing paper
“Second, *Tsc1*−/− hippocampal neurons were shown to have morphological and functional synaptic abnormalities[26](#R26).”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [26]
In the citing paper
“and TSC1 or TSC2 loss causes enlarged spines39.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [39]
In the citing paper
“Individuals with mutations of tuberous sclerosis proteins 1 and 2 (TSC1, TSC2) or the phosphatase and tensin homolog (PTEN) gene, which causes macroencephaly, are frequently diagnosed with autism38 and each of these proteins regulates synaptic structure39,40.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [39]
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 1×
“and upregulates mTOR, which, through multiple actions, enhances protein translation and cell growt”
BackgroundA simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P.-A., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,089 · cited 1×
“Organotypic slice cultures were prepared from P5–P7 mice and rat”
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · cited 1×
“In vitro , Akt phosphorylates TSC2 at conserved consensus phosphorylation sequences and downregulates its GTPase-activating protein (GAP) activit”
BackgroundSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex
Trachtenberg, J. T., Chen, B. E., Knott, G. W., Feng, G., Sanes, J. R., Welker, E., & Svoboda, K. (2002) · Nature · doi:10.1038/nature01273 · Cited by 1,927
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · cited 1×
“In vitro , Akt phosphorylates TSC2 at conserved consensus phosphorylation sequences and downregulates its GTPase-activating protein (GAP) activit”
BackgroundRegulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998) · Nature · doi:10.1038/31729 · Cited by 1,425
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043 · cited 1×
“Reduced GAP activity allows the buildup of GTP-bound Rhe”
BackgroundShrinkage of dendritic spines associated with long-term depression of hippocampal synapses
Zhou, Q., Homma, K. J., & Poo, M.-M. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.011 · Cited by 1,025
Cited by
Items 401–495 of 495
Oriented Markov Random Field Based Dendritic Spine Segmentation for Fluorescence Microscopy Images
Cheng, J., Zhou, X., Miller, E. L., Alvarez, V. A., Sabatini, B. L., & Wong, S. T. C. (2010) · Neuroinformatics · doi:10.1007/s12021-010-9073-y · Cited by 4
Self-citationEpilepsy in Tuberous Sclerosis Complex
Novegno, F., Massimi, L., & Rocco, C. D. (2012) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-7091-1360-8_6 · Cited by 6
“The soma size and dendrite size and density of hippocampal pyramidal cells are perturbed by the loss of a single copy of the TSC1 gene, which leads to increased AMPA receptor-mediated currents as well [ 107 ] .”
BackgroundThe Autistic Spectrum Disorders (ASD): From the Clinics to the Molecular Analysis
Roubertoux, P. L., & Tordjman, S. (2014) · Neuromethods · doi:10.1007/978-1-4939-2250-5_2 · Cited by 6
Genotype–phenotype correlations in tuberous sclerosis: Who and how to treat
Goh, S., & Weiss, W. A. (2006) · Annals of Neurology · doi:10.1002/ana.20917 · Cited by 4
“A recent study suggests that haploinsufficiency may contribute to the neuropathology and clinical manifestations of Tsc, because rodents haploinsufficient for Tsc1 or Tsc2 had large neuronal cell bodies in the hippocampus, enlargement and decreased densities of dendritic spines, and altered properties at glutamatergic…”
BackgroundNass, R. D., & Crino, P. B. (2008) · Neurology · doi:10.1212/01.wnl.0000305964.52343.8f · Cited by 4
Haile, H., Leskinen, S., Adapa, A. R., Goldberg, A. R., Viswanathan, A., Milligan, C., Conboy, K., Schevon, C. A., Canoll, P., & Gill, B. J. A. (2025) · Biomedicines · doi:10.3390/biomedicines13112593 · Cited by 3
“Beyond its role in NSC regulation, mTOR signaling shapes neuronal morphology, connectivity, and excitability of post-mitotic neurons [40,50–52].”
Neurobiology of Autism Spectrum Disorder
Casanova, M. F., Constantino, J. N., Ecker, C., Frye, R. E., Martínez‐Cerdeño, V., Rossignol, D. A., & Scherer, S. W. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_32 · Cited by 4
Pilipow, K., Basso, V., Migone, N., & Mondino, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091952 · Cited by 3
“In addition to gene inactivation, alternative mechanisms, such as differences in allele specific mRNA expression or haploinsufficiency have also been suggested to influence neuronal structure and function [18,19].”
BackgroundSynaptic Dysfunction Attributes to Autism Spectrum Disorder
Zhan, Y., & Kong, X. (2011) · North American Journal of Medicine and Science · doi:10.7156/v4i3p112 · Cited by 3
Gobert, D., Schohl, A., Kutsarova, E., & Ruthazer, E. S. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22782 · Cited by 3
“Furthermore, there is also in vitro evidence that mTOR can contribute to regulating dendritic spine shape and composition of glutamatergic synapses (Bateup et al., 2011; Henry et al., 2017; Tavazoie et al., 2005).”
BackgroundGenotype–Phenotype Studies in TSC and Molecular Diagnostics
Au, K. S., & Northrup, H. (2010) · doi:10.1002/9783527630073.ch5 · Cited by 3
Developmental Neurobiology of Autism Spectrum Disorders
Rubenstein, J. L. R. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780195371826.003.0035 · Cited by 3
Dendritic spine pathology in neuropsychiatric
Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2011) · Cited by 2
mTOR Signaling in Cortical Network Development
Lin, T. V., & Bordey, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-415804-7.00015-0 · Cited by 1
Long and Short-Term Effect of mTOR Regulation on Cerebral Organoid Growth and Differentiations
Park, S. B., Lim, B., Kim, K. Y., & Koh, B. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00611-3 · Cited by 3
Rat and Mouse Models of Tuberous Sclerosis
Kwiatkowski, D. J. (2010) · Wiley eBooks · doi:10.1002/9783527630073.ch7 · Cited by 2
Self-citationAutomated detection and time lapse analysis of dendritic spines in laser scanning microscopy images
Cheng, J. (2009) · Digital Repository Service (Northeastern University) · doi:10.17760/d10019303 · Cited by 2
Amaral, D. G., Rubenstein, J. L. R., & Rogers, S. J. (2008) · Wiley eBooks · doi:10.1002/9780470515167.ch23 · Cited by 2
Modeling Tuberous Sclerosis Complex: Brain Development and Hyperexcitability
Ess, K. C. (2009) · Neuromethods · doi:10.1007/978-1-60327-263-6_5 · Cited by 2
Benthall, K. N., Cording, K. R., Agopyan-Miu, A. H. C. W., Chen, E. Y., & Bateup, H. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.15.877126 · Cited by 2
Emerging Research towards the Understanding and Treatment of Autism
Wang, P. P., Hammond, R., Postma, F. R., & Healy, A. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00384 · Cited by 1
AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1
Haidar, E. A., Prabhakar, S., Geffrey, A. L., Mahamdeh, M., Tomeh, T., Breyne, K., Roumieh, E., Gurevich, M., Soberman, R. J., Wojtkiewicz, G. R., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101556 · Cited by 2
“18 Collectively, these data demonstrated that early postnatal Tsc1 deletion lead to pronounced defects in cortical organization, neuronal migration, and hippocampal integrity, and that systemic hamartin replacement did not notably rescue organization.”
Mei, X., Liu, Y., Fang, C., Guo, J., Tan, Y., Shi, Y., Xiao, J., & Qi, D. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01652-z · Cited by 1
“…which phosphorylate and inactivate CFL1, thereby disturbing actin dynamics [29]; mutations affecting CFL1 phosphorylation sites in patients with tuberous sclerosis correlate with seizure risk [30]; and pharmacological stabilization of F-actin exacerbates neuronal excitability in animal models [31].”
Translational Control of Synaptic Plasticity and Memory
Khoutorsky, A., Gkogkas, C. G., & Sonenberg, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3991-2_14 · Cited by 1
Chromosomal Abnormalities and Putative Susceptibility Genes in Autism Spectrum Disorders
Gilling, M. (2015) · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
From Molecular Pathways to ASD Therapy: Insights from Syndromic Forms of Autism
Nicholls, L. E., Ramadas, R., & Voineagu, I. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0002 · Cited by 1
Jo, Y.-G., Kim, M., Shin, H., Lee, K. Y., & Lee, E. J. (2019) · Natural Product Sciences · doi:10.20307/nps.2019.25.4.298 · Cited by 1
Novegno, F., & Rocco, C. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-31512-6_45-1 · Cited by 1
Mitochondrial Dysfunction and mTOR in Autism Spectrum Disorders
SELAMET, E., & Usta, M. B. (2023) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1205786 · Cited by 1
The Development of Methods of BLOTCHIP®-MS for Peptidome: Small Samples in Tuberous Sclerosis
Yui, K., Imataka, G., Yuge, K., Sasaki, H., Shiohama, T., Asada, K., & Tachiki, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010034 · Cited by 1
“Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC [9].”
InfluentialA Neurodevelopmental Perspective for Autism-Associated Gene Function
Poquérusse, J., & Luikart, B. W. (2017) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1702004 · Cited by 2
“Such genes include β-catenin (CTNNB1), a regulator of cell-cell adhesion and gene transcription, as well as dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), chromo-helicase domain protein 8 (CHD8), and ubiquitin protein ligase E3A (UBE3A).”
BackgroundFamilial tumour syndromes: tuberous sclerosis complex
Weiner, H. L., & Crino, P. B. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780199651870.003.0017 · Cited by 1
Tuberous sclerosis: genes, brain, and behaviour
Curatolo, P. (2007) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2006.tb01285.x · Cited by 1
Regulation of the mammalian target of rapamycin complex 2 (mTORC2)
Molle, K. D. (2006) · edoc (University of Basel) · doi:10.5451/unibas-004670272 · Cited by 1
Connolly, K. J., O'Hare, M. B., Mohammed, A., Aitchison, K. M., Anthoney, N. C., Taylor, M. J., Stewart, B. A., Tuxworth, R. I., & Tear, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/278895 · Cited by 1
Boosting L-type Ca 2+ channel activity in tuberous sclerosis mitigates excess glutamate receptorsPreprint
Niere, F., Cacheaux, L. P., Egido‐Betancourt, H. X., Taylor, W. C., & Raab‐Graham, K. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.26.269209 · Cited by 1
“Moreover, GluA-mediated currents are enhanced in a Tsc1 KO mouse model (25, 26).”
BackgroundLepagnol-Bestel, A.-M., Duchon, A., Viard, J., Kvajo, M., Daudin, R., Khelfaoui, M., Haziza, S., Loe-Mie, Y., Aime, M., Suizu, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.01.518705 · Cited by 1
“Furthermore, AKT/mTORC1 pathway was already involved in the pathophysiology of ASD for TSC1/TSC2 (23) and for Shank3 (24).”
BackgroundCHARACTERIZATION AND TREATMENT OF A NOVEL MOUSE MODEL OF TSC-ASSOCIATED AUTISM
Reith, R. M. (2012) · Digital Commons-TMC (Texas Medical Center)
Goorden, S. M. I. (2012) · EUR Research Repository (Erasmus University Rotterdam)
The role of TSC2 and deptor in fetal cortical development
Tsai, V. (2012) · ScholarlyCommons (University of Pennsylvania)
Thiele, E. A., & Weiner, H. L. (2010) · doi:10.1002/9783527630073.ch10
Zurashvili, T. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The management of drug resistant seizures in tuberous sclerosis
Curatolo, P., Bombardieri, R., Pinci, M., & Moavero, R. (2009) · Journal of Pediatric Sciences · doi:10.17334/jps.81324
Beck, D., Zhou, X., Pham, T., Sabatini, B. L., & Wong, S. T. C. (2009) · IEEE/NIH Life Science Systems and Applications Workshop · doi:10.1109/lissa.2009.4906703
Self-citationNetwork based analysis of genetic disease associations
Gilman, S. R. (2013) · doi:10.7916/d8k9370f
“mTOR integrates various inputs from upstream growth-related pathways, and is also known to regulate dendrite morphogenesis [34].”
BackgroundMore than mTOR? Novel Roles for MEK-ERK1/2 and FLNA in Tuberous Sclerosis Complex
Dulla, C. G. (2015) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-15.4.221
“In 2005, an important study demonstrated that loss of Tsc1 or Tsc2 caused mTOR-dependent enlargement of neuronal soma and dendritic spines via cofilin, a molecule involved in actin depolymerization (7).”
BackgroundSelleck, S. B. (2012) · Defense Technical Information Center (DTIC) · doi:10.21236/ada603854
Wilson, N. R., & Sur, M. (2011) · The MIT Press eBooks · doi:10.7551/mitpress/9780262015233.003.0007
“2 brings about a fundamental shift in spine morphology— converting numerous small spines into fewer large spines, with stronger excitatory transmission (Tavazoie et al., 2005).”
BackgroundMouse Models of Tuberous Sclerosis
Ehninger, D. (2014) · Neuromethods · doi:10.1007/978-1-4939-2250-5_17 · Cited by 1
TUBERIN REGULATION IN NEURAL TISSUE AND CELL FATE
Khatir, B. A. (2016) · Scholarship at UWindsor (University of Windsor)
Targeting the PI3K/Akt/mTOR pathway in traumatic brain injury and developmental disease
Nikolaeva, I. (2016) · doi:10.7282/t3cz39bh · Cited by 2
Behavioral Analysis and Rescue of a Novel Cerebellar Mouse Model of Tuberous Sclerosis Complex
Gambello, M. J. (2012) · Defense Technical Information Center (DTIC) · doi:10.21236/ada566012
The signal transduction of synapse formation and it's failure in Rett syndrome
Ebrecht, R. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6271
Multiple Levels of Synaptic Regulation by NMDA-type Glutamate Receptor in Normal and Disease States
Alvarez, V. A., Shankar, G. M., Bloodgood, B. L., Selkoe, D. J., & Sabatini, B. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-76330-7_7
“This vector, named shNR1, also expresses a fluorescent marker (GFP) that allows for the identification of the transfected neuron and analysis of its morphology ( Tavazoie et al. 2005 ).”
Self-citationJohnston, M. V., & Jangouk, P. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717957730.793462142
Johnston, M. V., & Gipson, T. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718008457.793476208
Drescher, U. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717954165.793459911
Casanova, M. F., Amaral, D. G., Rubenstein, J. L. R., & Rogers, S. J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch23
Novegno, F., & Rocco, C. D. (2020) · Springer eBooks · doi:10.1007/978-3-319-72168-2_45
Ganga, H. (2022) · International journal of high school research · doi:10.36838/v4i2.9
Zhang, Y. (2006) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2443
Understanding neurodegeneration with multi-scale images: an integrated neural image analysis system
Fan, J. (2013) · Digital Repository Service (Northeastern University) · doi:10.17760/d20004834
Girirajan, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732015148.793556414
Hell, J. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732438273.793543513
Popovich, P. G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733249934.793557644
Berthoux, C., Hamieh, A. M., Rogliardo, A., Doucet, E. L., Coudert, C., Ango, F., Grychowska, K., Chaumont‐Dubel, S., Zajdel, P., Maldonado, R. J., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216481
Kinase Inhibitors in Genetic Diseases
D’Antona, L., Amato, R., Brescia, C., Rocca, V., Colao, E., Iuliano, R., Blazer‐Yost, B. L., & Perrotti, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065276
“Specifically, mTOR activation leads to increased dendritic protein synthesis, with long-term depression mediated by alterations in the postsynaptic glutamate receptor [55,56] also leading to memory deficits in patients with autism spectrum disorders.”
BackgroundNeurobiology of Autism Spectrum Disorder
Casanova, M. F., Constantino, J. N., Ecker, C., Frye, R. E., Martínez‐Cerdeño, V., Rossignol, D. A., & Scherer, S. W. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_32-1
Białoń, N., Suszyńśki, K., Górka, M., Trzęsicki, M., Górka, D., Zając, K., & Kupczak, A. (2023) · Postępy Biochemii · doi:10.18388/pb.2021_489 · Cited by 1
Dendritic arbor dynamics and stability in health and disease
Mlostek, M., Zeng, J., Urbańska, M., & Jaworski, J. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-2456 · Cited by 1
Cenobamate's Efficacy for Seizure Treatment in Patients with Tuberous Sclerosis ComplexPreprint
Aungaroon, G., Cooke, A., Ritter, D., Horn, P. S., Krueger, D. A., & Franz, D. N. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4893029
Wang, C., Zhai, J.-X., & Chen, Y. (2024) · Medicine · doi:10.1097/md.0000000000040151
“[2,3] It was first described in depth in Bernville in 1880, and it is now estimated that nearly 2 million people worldwide are affected by the disease.”
BackgroundSulfamethizole Attenuates Pentylenetetrazole‐Induced Seizures in Mice via mTOR Inhibition
Kambli, L., Raut, D., & Bhatt, L. K. (2024) · Drug Development Research · doi:10.1002/ddr.70039
“…have suggested the role of the mammalian target of rapamycin (mTOR), which is a serine/threonine ‐ protein kinase, in epileptogenesis (Curatolo and Moavero 2013). mTOR signaling is involved in dendritic development, CNS development, and synaptic plasticity (Tavazoie et al. 2005; Chong et al. 2010).”
A review of epilepsy syndromes and epileptogenic mechanism affiliated with brain tumor related genes
Chan, C.-K., Lim, K. S., Chan, C.-Y., Kumar, T. S., Audrey, C., Narayanan, V., Fong, S., & Ng, C. C. (2025) · Gene · doi:10.1016/j.gene.2025.149531
Darghouthi, M., Soltani, I., Bahia, W., Slaymi, C., guedria, A., Gaddour, N., Almawi, W. Y., & Ferchichi, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05561-6
“Using models of mice, it has been demonstrated that anomalies in the structure and function of neurons are caused by the loss of a single TSC allele [67].”
Hien, A., Molinaro, G., Liu, B., Huber, K. M., & Richter, J. D. (2020) · Figshare · doi:10.6084/m9.figshare.13093721
Alsaqati, M., Heine, V. M., & Harwood, A. J. (2020) · Figshare · doi:10.6084/m9.figshare.13115516
Maman, M., Ando, K., Fisher, N., Thomas, C., Levy, Y., Bond, G., Kagan, T., Malchenko, N., Desbois, M., Zaken, S. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.25.693346
“8A) , which was consistent with previous findings 67 .”
Hsieh, C. C., Huang, N., Tung, S.-Y., Lin, W.-X., Wang, H., Nguyen, T. T. A., Chern, Y., & Lee, Y. (2026) · Cell & Bioscience · doi:10.1186/s13578-025-01518-3
Voniati, L., Chrysanthou, L., & Georgiou, R. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00153-x
“Molecular data suggest that axonal arborization, synaptic formation, and reduced myelination contribute to the reduction in white matter observed in TSC [13–15], Bayraktar et al [2].”
Altered striatal long-term potentiation in the eIF4E- TG ASD mouse modelPreprint
Aaltonen, A., Razquin, J., Oyrer, J., Criscuolo, C., Lieberman, O. J., Klann, E., Borgkvist, A., & Santini, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709616
Altered striatal long-term potentiation in the eIF4E-TG mouse model of autism spectrum disorder
Aaltonen, A., Razquin, J., Garton, D. R., Oyrer, J., Criscuolo, C., Lieberman, O. J., Klann, E., Borgkvist, A., & Santini, E. (2026) · iScience · doi:10.1016/j.isci.2026.117278
“38,39 37, 72 We have previously identified”
Les mécanismes antiépileptiques de l’AppCH2ppA dans la sclérose tubéreuse de Bourneville
Pons-Bennaceur, A. (2018) · theses.fr (ABES) · doi:10.70675/bc0fd846z6521z4538zb18cz82c70f31c458
Investigations génétiques et physiopathologiques des dysplasies corticales focales de type 2
Ribierre, T. (2020) · theses.fr (ABES) · doi:10.70675/7ac267e2z8712z4e0fza9a1z424bc9445787
Role of the mTOR-downstream effector S6K1 in tuberous sclerosis complex neurological manifestations
Avanzi, F. (2023) · theses.fr (ABES) · doi:10.70675/20853cbdz078bz47dcza392zaeb61eb11f48
Pineau, L. (2023) · theses.fr (ABES) · doi:10.70675/39c790cfzdf57z416bzb9cez06eca43d9cda
Is Nuclear mTOR Relevant for Neuronal Dysfunction?
Kumari, S., Pagano, R., Orzoł, K., & Jaworski, J. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70528 · Cited by 1
“…mTORC1 activity or manipulating downstream effectors such as 4E-BP1 or S6K1 partially reverses structural and electrophysiological abnormalities (Tavazoie et al. 2005; Sato et al. 2012; Ehninger et al. 2008; Meikle et al. 2007; Karalis et al. 2022; Kedra et al. 2020; Doszyn et al. 2024; Zeng et…”
Amegandjin, C. A., Carreño-Muñoz, M. I., Francavilla, R., Kamda, J. L. D., Roussel, M., do Nascimento, A. S. F., Farley, A., Chehrazi, P., Chama, A. G. C., Chattopadhyaya, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.22.740050
van Altena, P. F. J., Ransanz, L. C., Guis, R. H., Bergamaschi, G., Paauw, N. J., Staufer, U., Heine, V. M., & Accardo, A. (2026) · Advanced Materials · doi:10.1002/adma.74596
Metadata
- Authors
- Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sabatini, Bernardo L
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2005-11-06
- Volume
- 8
- Issue
- 12
- Pages
- 1727-1734
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1977617725
- Cited by
- 497
- References
- 51
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 14 · 2023: 17 · 2022: 17 · 2021: 21 · 2020: 29 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 29 · 2012: 45
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (5 T32 NS07484, T32NS007484)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- TSC1, TSC2, tuberous sclerosis complex, neuronal morphology, dendritic spines, hippocampal pyramidal neurons, glutamatergic synapses, cofilin, actin cytoskeleton, epilepsy, autism spectrum disorder, intellectual disability
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Brain, Cell Differentiation, Cell Line, Hippocampus, Humans, Mice, Transgenic, Neurons, Phosphorylation, Tuberous Sclerosis, Rats, Sprague-Dawley, Pyramidal Cells, Mice, Knockout, Gene Expression Regulation, Developmental, Tumor Suppressor Proteins, Cell Shape, Dendritic Spines, Cofilin 1, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.